Anti-allergic 3-indolecarboxamides
    1.
    发明授权
    Anti-allergic 3-indolecarboxamides 失效
    抗过敏3-吲哚酰胺

    公开(公告)号:US4576940A

    公开(公告)日:1986-03-18

    申请号:US639292

    申请日:1984-08-10

    CPC分类号: C07D401/12 C07D403/12

    摘要: 3-Indolecarboxamide compounds of the formula: ##STR1## inclusive of pharmaceutically acceptable acid addition salt and/or hydrate forms thereof, wherein R.sup.1 is C.sub.1-8 alkyl, C.sub.3-8 cycloalkyl, C.sub.3-8 cycloalkyl-C.sub.1-8 alkyl, allyl, propargyl, or phenyl or phenyl-C.sub.1-4 alkyl which may be optionally substituted, on the benzene ring, by at least one substituent selected from the group consisting of halogen, trifluoromethyl, C.sub.1-4 alkyl and C.sub.1-4 alkoxy; R.sup.2 is H or C.sub.1-6 alkyl; R.sup.3 is H, halogen, C.sub.2-6 alkanoyloxy, benzoyloxy, C.sub.1-4 alkoxy, benzyloxy, hydroxy or C.sub.1-4 alkyl; R.sup.4 is H, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy or hydroxy; R.sup.5 is H or C.sub.1-4 alkoxy; A is ethylene or trimethylene, which may be optionally substituted by C.sub.1-4 alkyl; n is zero, 1 or 2; and m is zero or 1, are useful as drugs for the prevention and treatment of various allergic diseases.

    摘要翻译: 具有下式的3-吲哚甲酰胺化合物:包括其药学上可接受的酸加成盐和/或其水合物形式,其中R 1是C 1-8烷基,C 3-8环烷基,C 3-8环烷基-C 1-8烷基,烯丙基, 炔丙基,或苯基或可任意取代的苯基-C 1-4烷基在苯环上,被至少一个选自卤素,三氟甲基,C 1-4烷基和C 1-4烷氧基的取代基取代; R2是H或C1-6烷基; R3是H,卤素,C2-6烷酰氧基,苯甲酰氧基,C1-4烷氧基,苄氧基,羟基或C1-4烷基; R4是H,卤素,C1-4烷基,C1-4烷氧基或羟基; R5是H或C1-4烷氧基; A是乙烯或三亚甲基,其可任选被C 1-4烷基取代; n为零,1或2; m为0或1,可用作预防和治疗各种过敏性疾病的药物。

    Anti-hypertensive 9-aminomethyl-benzo[f]quinoline-3,10-dione derivatives
    2.
    发明授权
    Anti-hypertensive 9-aminomethyl-benzo[f]quinoline-3,10-dione derivatives 失效
    抗高血压9-氨基甲基 - 苯并[f]喹啉-3,10-二酮衍生物

    公开(公告)号:US4543354A

    公开(公告)日:1985-09-24

    申请号:US550423

    申请日:1983-11-10

    摘要: Benzo[f]quinoline derivatives which are useful as antihypertensive agents and are represented by the formula: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl, R.sup.2 is hydrogen, lower alkyl, hydroxy-lower-alkyl or lower-alkoxy-lower-alkyl, R.sup.3 and R.sup.4 are the same or different and each is hydrogen, lower alkyl, halogen, lower alkoxy, benzyloxy or hydroxy, R.sup.5 and R.sup.6 are the same or different and each is hydrogen, straight or branched alkyl, aralkyl or cycloalkyl, or R.sup.5 and R.sup.6 together with the adjacent nitrogen atom form a heterocycle, and the dotted line in the ring is an optional bond between 1- and 2-positions, and pharmaceutically acceptable acid addition salts thereof.

    摘要翻译: 苯并[f]喹啉衍生物,其可用作抗高血压剂并由下式表示:其中R 1为氢或低级烷基,R 2为氢,低级烷基,羟基 - 低级烷基或低级烷氧基 - 低级烷基 R 3和R 4相同或不同,各自为氢,低级烷基,卤素,低级烷氧基,苄氧基或羟基,R 5和R 6相同或不同,各自为氢,直链或支链烷基,芳烷基或环烷基或R5 和R6与相邻的氮原子一起形成杂环,并且环中的虚线是1-位和2-位之间的任选键及其药学上可接受的酸加成盐。

    5-Hydroxyindole-3-carboxylic acid amide compounds, pharmaceutical
compositions and use
    3.
    发明授权
    5-Hydroxyindole-3-carboxylic acid amide compounds, pharmaceutical compositions and use 失效
    5-羟基吲哚-3-羧酸酰胺化合物,药物组合物和用途

    公开(公告)号:US4874759A

    公开(公告)日:1989-10-17

    申请号:US261836

    申请日:1988-09-23

    IPC分类号: C07D209/42 C07D401/12

    CPC分类号: C07D401/12 C07D209/42

    摘要: Hydroxyindole-3-carboxylic acid amide compounds of the general formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are, the same or different, respectively a hydrogen atom, an alkyl group, an aryl group, an aralkyl group or a heteroaryl group, or R.sup.1 and R.sup.2 and/or R.sup.3 and R.sup.4 are respectively groups which are combined to each other taken together with the adjacent nitrogen atom to form a heterocyclic group, R.sup.5 is an alkyl group, R.sup.6 is a hydrogen atom, an alkyl group, a cycloalkyl group, an aryl group or an aralkyl group and X is a hydrogen atom, a halogen atom or a lower alkanoyl group, or their acid addition salts.These compounds are of use as diuretics or a therapeutic medicine for circulation system diseases.

    3-indolecarboxamides for control of circulatory diseases
    4.
    发明授权
    3-indolecarboxamides for control of circulatory diseases 失效
    3-indolecarboxamides用于控制循环系统疾病

    公开(公告)号:US4581355A

    公开(公告)日:1986-04-08

    申请号:US680727

    申请日:1984-12-12

    CPC分类号: C07D401/12 C07D403/12

    摘要: 3-Indolecarboxamide compounds of the formula: ##STR1## inclusive of pharmaceutically acceptable acid addition salt and/or hydrate forms thereof, wherein R.sup.1 is hydrogen or C.sub.1-4 alkyl; each of R.sup.2 and R.sup.3 is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, benzyloxy, C.sub.2-6 alkanoyloxy or hydroxy; R.sup.4 is hydrogen or C.sub.1-4 alkyl; R.sup.5 is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy or hydroxy; R.sup.6 is hydrogen or C.sub.1-4 alkyl; X is oxygen, sulfur or direct bond; each of k and m is an integer of 1 to 3; and n is 1 or 2, are useful as drug for the prevention and treatment of various circulatory diseases.

    摘要翻译: 具有下式的3-吲哚甲酰胺化合物:包括其药学上可接受的酸加成盐和/或其水合物形式,其中R 1是氢或C 1-4烷基; R 2和R 3各自为氢,卤素,C 1-4烷基,C 1-4烷氧基,苄氧基,C 2-6烷酰氧基或羟基; R4是氢或C1-4烷基; R5是氢,卤素,C1-4烷基,C1-4烷氧基或羟基; R6是氢或C1-4烷基; X是氧,硫或直接键; k和m各自为1〜3的整数, 和n为1或2,可用作预防和治疗各种循环系统疾病的药物。

    Operating method of vacuum processing system and vacuum processing system
    7.
    发明授权
    Operating method of vacuum processing system and vacuum processing system 有权
    真空处理系统和真空处理系统的操作方法

    公开(公告)号:US06941185B2

    公开(公告)日:2005-09-06

    申请号:US10140120

    申请日:2002-05-08

    摘要: A vacuum processing apparatus and method wherein a plurality of processing units are for conducting processing, a transfer processing unit is connected with the plurality of processing units for carrying wafers to the processing units, a transfer device is disposed in the transfer processing unit and carries the wafers and cassettes for containing the wafers, and a control unit is provided for conducting transfer control for transferring the wafers from respective cassettes to the transfer processing unit. The wafers are processed by using the plural processing units, and at least two of the cassettes are used. Parallel processing is conducted of applying same processing to the wafers contained on each of the cassettes by applying the same recipe and the wafers, after applying the parallel processing, are returned to the original cassette.

    摘要翻译: 一种真空处理装置和方法,其中多个处理单元用于进行处理,转移处理单元与用于将晶片运送到处理单元的多个处理单元连接,转移装置设置在转移处理单元中,并携带 用于容纳晶片的晶片和盒,以及控制单元,用于进行用于将晶片从相应的盒传送到传送处理单元的传送控制。 通过使用多个处理单元处理晶片,并且使用至少两个盒。 通过施加相同的配方,对包含在每个盒中的晶片进行相同的处理,并行处理,并且在施加并行处理之后,晶片返回到原始盒。

    Self-ballasted fluorescent lamp
    8.
    发明授权
    Self-ballasted fluorescent lamp 失效
    自镇流荧光灯

    公开(公告)号:US06225742B1

    公开(公告)日:2001-05-01

    申请号:US09640423

    申请日:2000-08-17

    IPC分类号: H01J744

    CPC分类号: H01J61/325

    摘要: A high wattage self-ballasted fluorescent lamp includes a fluorescent tube including a pair of electrodes inside, an electronic ballast circuit portion, an outer bulb, a resin case and a lamp base. (i) The outer bulb has an outer diameter of 60 mm to 70 mm, an outer diameter of a bottom portion of 50 mm to 58 mm, and a total length of 73 mm to 85 mm. (ii) The resin case has an outer diameter of 50 mm to 58 mm. (iii) The total length of the self-ballasted fluorescent lamp is not more than 148 mm. The fluorescent tube has a distance between the electrodes of 450 mm to 540 mm and an inner diameter of 8.0 mm to 10.0 mm, and is operated at a lamp current of not more than 220 mA. Thus, the self-ballasted fluorescent lamp can be compact so that the light fixture application ratio can be improved. Moreover, the self-ballasted fluorescent lamp has a lifetime as long as 6000 hours and a lamp efficiency as high as 66 lm, and the power consumption can be reduced.

    摘要翻译: 高功率自镇流荧光灯包括内部包括一对电极的荧光管,电子镇流器电路部分,外部灯泡,树脂壳体和灯座。 (i)外灯泡具有60mm至70mm的外径,底部的外径为50mm至58mm,总长度为73mm至85mm。 (ii)树脂外壳的外径为50mm〜58mm。 (iii)自镇流荧光灯的总长度不超过148mm。 荧光管的电极间距离为450mm〜540mm,内径为8.0mm〜10.0mm,灯管电流为220mA以下。 因此,自镇流荧光灯可以是紧凑的,从而可以提高照明灯具的使用比例。 此外,自镇流荧光灯的寿命长达6000小时,灯效率高达66lm,并且能够降低功耗。